Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | CAD 366.15M | -247x | -3.91 | CAD 51.98 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | CAD 278.94M | -166.2x | -1.8 | CAD 10.14 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | CAD 248.30M | -2.3x | -0.05 | CAD 11.80 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | CAD 203.05M | -3.6x | -0.22 | CAD 5.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ME Therapeutics Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 196.42M | -158.1x | -1.83 | CAD 7.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | CAD 194.05M | -6.8x | 0.72 | CAD 2.76 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | CAD 145.93M | -3.3x | 0.25 | CAD 0.88 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.2% Upside | Upgrade to Pro+ | |
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | CAD 137.64M | -12.9x | -1.53 | CAD 1.32 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 135.46M | -3x | 0.17 | CAD 1.66 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | CAD 81.34M | -2.8x | 0.05 | CAD 1.04 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | CAD 73.22M | -2.6x | -0.1 | CAD 0.95 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 63M | -372.5x | -2.7 | CAD 1.22 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 62.53M | 31.4x | -0.68 | CAD 0.44 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sharp Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 62.09M | -0x | CAD 2.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | CAD 59.49M | -1.5x | 0.45 | CAD 0.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 57.36M | -0.2 | CAD 1.19 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 57.36M | -0.2 | CAD 1.19 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 51.96M | -4.8x | 0.14 | CAD 0.98 | 10.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | CAD 50.10M | -6.1x | 0.05 | CAD 0.28 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | CAD 40.64M | -6.1x | -0.31 | CAD 0.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | CAD 34.72M | -4.6x | -0.1 | CAD 0.31 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | CAD 34.63M | -10.4x | 4.39 | CAD 0.31 | 10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 30.49M | -7x | 4.54 | CAD 0.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hemostemix Inc | TSXV | Healthcare | Biotechnology & Medical Research | CAD 26.23M | -8.2x | -0.3 | CAD 0.18 | 12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 19.64M | -2.2x | 0.48 | CAD 0.14 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 19.33M | -0.3x | -0.02 | CAD 5.21 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmala Biotech Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 18.62M | CAD 0.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 17.93M | -7.6x | 0.32 | CAD 0.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sirona Biochem Corp | TSXV | Healthcare | Biotechnology & Medical Research | CAD 17.14M | -6.5x | 0.46 | CAD 0.06 | 16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numinus Wellness Inc | Toronto | Healthcare | Biotechnology & Medical Research | CAD 16.12M | -0.5x | -0.01 | CAD 0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | CAD 15.81M | -0.05 | CAD 0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 15.68M | -0.6x | 0.07 | CAD 0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | CAD 15.68M | -0.6x | 0.07 | CAD 0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | CAD 15.18M | -0.2x | 0.02 | CAD 4.04 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | CAD 12.70M | -0.22 | CAD 0.08 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | CAD 12.70M | -0.22 | CAD 0.08 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | CAD 12.68M | -0.8x | -0.05 | CAD 0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum BioPharma | CSE | Healthcare | Biotechnology & Medical Research | CAD 12.33M | -0.3x | -0.01 | CAD 6.40 | -9.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innovotech | TSXV | Healthcare | Biotechnology & Medical Research | CAD 8.95M | -25.7x | 1.59 | CAD 0.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CSE | Healthcare | Biotechnology & Medical Research | CAD 7.68M | -1.1x | -0.03 | CAD 0.10 | 53.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CBOE Canada | Healthcare | Biotechnology & Medical Research | CAD 7.68M | -1.1x | -0.03 | CAD 0.10 | 61.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicure | TSXV | Healthcare | Biotechnology & Medical Research | CAD 6.99M | -3.4x | 0.01 | CAD 0.67 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alpha Cognition | CBOE Canada | Healthcare | Biotechnology & Medical Research | CAD 6.31M | -0.6x | 0.01 | CAD 0.31 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marvel Biosciences | TSXV | Healthcare | Biotechnology & Medical Research | CAD 6.27M | -5x | -0.1 | CAD 0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Principal Tech | TSXV | Healthcare | Biotechnology & Medical Research | CAD 6.20M | -2.8x | 0.28 | CAD 0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StageZero Life Sciences | Toronto | Healthcare | Biotechnology & Medical Research | CAD 4.94M | -0.2x | CAD 0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
XORTX Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | CAD 4.94M | -3.4x | -0.05 | CAD 1.42 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Appili Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | CAD 4.24M | -1.1x | -0.04 | CAD 0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revive Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 4.19M | -1.8x | -0.87 | CAD 0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revive Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | CAD 4.19M | -1.8x | -0.87 | CAD 0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |